Suriname vs United States: Average non-HDL cholesterol levels
Suriname
3.3
in 2018
United States
3.3
in 2018
Suriname rank
95th
United States rank
95th
Average non-HDL cholesterol levels over time
- Suriname
- United States
How they compare
Suriname currently reports 3.3 against 3.3 in United States, a difference of 0.
Across all 39 years both countries report, United States has been ahead every year.
Suriname ranks 95th and United States ranks 95th of 191 countries.
United States has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Suriname | United States | Difference | Ahead |
|---|---|---|---|---|
| 1980s | 3.5 | 3.93 | 0.43 | United States |
| 1990s | 3.45 | 3.75 | 0.3 | United States |
| 2000s | 3.4 | 3.55 | 0.15 | United States |
| 2010s | 3.34 | 3.36 | 0.0111 | United States |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher average non-hdl cholesterol levels, Suriname or United States?
- Suriname, at 3.3 against 3.3 in United States as of 2018.
- What is the difference in average non-hdl cholesterol levels between Suriname and United States?
- 0, with Suriname ahead.
- How many years of comparable data are there for Suriname and United States?
- 39 years are reported by both, from 1980 to 2018.
- How do Suriname and United States rank globally for average non-hdl cholesterol levels?
- Suriname ranks 95th and United States ranks 95th of 191 countries.
- Where does this data come from?
- World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Average non-HDL cholesterol levels. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The estimated average level of non-high-density lipoprotein (non-HDL) cholesterol, commonly known as "bad cholesterol". Healthy levels are considered to be under 4mmol/L. Elevated levels of non-HDL cholesterol are a risk factor for chronic complications, including cardiovascular disease, and premature death.